Choroideremia Research Foundation Acquires Spark Therapeutics, Inc., CHM Gene Therapy Assets, Advances Data Analysis

CRF acquired Spark Therapeutics, Inc.’s SPK-7001 CHM gene therapy assets and is analyzing long-term data to identify ...
Drexel University

Spark Therapeutics to Invest $575M in New State-of-the-Art Gene Therapy Innovation Center on Drexel’s University City Campus

Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, ...
Drexel University

Drexel University/Spark Therapeutics Gene Therapy Symposium: A Co-Sponsored Event

Please join us for a Gene Therapy Symposium that will convene faculty and researchers from Drexel University and Spark Therapeutics to present the latest developments in gene therapies research and ...
The Business Journals

Spark Therapeutics laying off more than half its staff

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The job cuts will take place in ...
The Business Journals

Spark Therapeutics trimming staff, product development programs

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Philadelphia gene therapy ...
Reuters

Spark licenses blindness gene therapy rights outside U.S. to Novartis

(Reuters) - Spark Therapeutics Inc, whose breakthrough gene therapy to treat a rare form of blindness was approved by U.S. regulators in December, said on Wednesday that it had licensed rights to the ...